Topical anti-cancer drug could have anti-aging potential
An anti-cancer drug could improve wrinkles and age spots by a mechanism similar to laser resurfacing, according to a study by American researchers.
Topical application of the drug fluorouracil is used to reduce potentially precancerous skin patches called actinic keratoses, according to the study published in the Archives of Dermatology.
After such treatment, improvements have been seen in photoaged skin, write the authors led by Dana Sachs at the University of Michigan, leading to the current study that attempts to characterise in more detail these potentially positive side effects.
